Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Solano

Showing results (211-220 of 273) with videos related to

Pageof 28
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2010
Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft sourceChristelle Ferrá, Jaime Sanz, Rafael de la Cámara, et al.
Eclinicalmedicine|April 12, 2021
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipientsPer Ljungman, Arancha Bermudez, Aaron C Logan, et al.
Bone Marrow Transplantation|June 19, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL)Anna Ossami Saidy, Ariane Boumendil, Peter Dreger, et al.
Blood|July 2, 2002
Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblingsAlvaro Urbano-Ispizua, Ciril Rozman, Pedro Pimentel, et al.
Leukemia & Lymphoma|June 11, 2014
Outcome of graft failure after allogeneic stem cell transplant: study of 89 patientsChristelle Ferrà, Jaime Sanz, Miguel-Angel Díaz-Pérez, et al.
Hemasphere|October 7, 2025
Patterns of immune recovery after axicabtagene ciloleucel for aggressive B-cell lymphomaAndré Airosa Pardal, Ana Benzaquén, Pablo Granados, et al.
American Journal of Hematology|May 23, 2024
Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationRaynier Devillier, Jacques-Emmanuel Galimard, Didier Blaise, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2015
Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante HematopoyeticoGuillermo Orti, Jaime Sanz, Arancha Bermudez, et al.
Blood Advances|January 4, 2018
Single umbilical cord blood with or without CD34<sup>+</sup> cells from a third-party donor in adults with leukemiaJaime Sanz, Mi Kwon, Guiomar Bautista, et al.
Bone Marrow Transplantation|June 10, 2022
Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemiaLorenzo Lazzari, Aitana Balaguer-Roselló, Juan Montoro, et al.
Pageof 28

Showing results (211-220 of 273) with videos related to

Sort By:
Pageof 28
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2010
Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft sourceChristelle Ferrá, Jaime Sanz, Rafael de la Cámara, et al.
Eclinicalmedicine|April 12, 2021
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipientsPer Ljungman, Arancha Bermudez, Aaron C Logan, et al.
Bone Marrow Transplantation|June 19, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL)Anna Ossami Saidy, Ariane Boumendil, Peter Dreger, et al.
Blood|July 2, 2002
Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblingsAlvaro Urbano-Ispizua, Ciril Rozman, Pedro Pimentel, et al.
Leukemia & Lymphoma|June 11, 2014
Outcome of graft failure after allogeneic stem cell transplant: study of 89 patientsChristelle Ferrà, Jaime Sanz, Miguel-Angel Díaz-Pérez, et al.
Hemasphere|October 7, 2025
Patterns of immune recovery after axicabtagene ciloleucel for aggressive B-cell lymphomaAndré Airosa Pardal, Ana Benzaquén, Pablo Granados, et al.
American Journal of Hematology|May 23, 2024
Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationRaynier Devillier, Jacques-Emmanuel Galimard, Didier Blaise, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2015
Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante HematopoyeticoGuillermo Orti, Jaime Sanz, Arancha Bermudez, et al.
Blood Advances|January 4, 2018
Single umbilical cord blood with or without CD34<sup>+</sup> cells from a third-party donor in adults with leukemiaJaime Sanz, Mi Kwon, Guiomar Bautista, et al.
Bone Marrow Transplantation|June 10, 2022
Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemiaLorenzo Lazzari, Aitana Balaguer-Roselló, Juan Montoro, et al.
Pageof 28